Gene delivery technologies company SIRION Biotech GmbH reported on Monday revenues of EUR3.1m for its vector design and manufacturing service for the first half of 2020.
This marks a growth of 26% when compared to the same period in 2019.
The company added that the prior year figures have been adjusted for a market approval milestone by one of its licensees.
For the whole of 2020 the company projects revenue of approximately EUR11.0m, which would exceed last year's revenue record.
Lilly declares Q2 2025 dividend
Bruker acquires majority stake in RECIPE to expand clinical mass spectrometry diagnostics
Emmaus Life Sciences reports drop in revenues, increased loss in 2024
L'Oréal and WHO Foundation partner to expand global skin health access